PEGRIZEPRUMENT
UNII BCH73Z4RPX

Substance Identification & Data

This profile provides standardized clinical and technical data for Pegrizeprument, uniquely identified by the FDA Unique Ingredient Identifier (UNII) BCH73Z4RPX.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2829316-24-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

BCH73Z4RPX

CAS Registry Number

2829316-24-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PEGRIZEPRUMENT

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C206965

National Cancer Institute reference terminology for clinical and research data.

INN ID

12997

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

NO-17

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pegrizeprument. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PEGRIZEPRUMENT

Common Names & Synonyms

IMMUNOGLOBULIN FAB VH-G1CH1H_L-KAPPA, ANTI-(HOMO SAPIENS CD28 (T CELL SPECIFIC SURFACE GLYCOPROTEIN CD28, TP44)), CONJUGATED TO A BI-BRANCHED POLYETHYLENE GLYCOL (PEG) CHAIN

IMMUNOGLOBULIN IGG1 FAB FRAGMENT, ANTI-(HUMAN CD28 ANTIGEN) (HUMAN MONOCLONAL VEL-101 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL VEL-101 .KAPPA.-CHAIN, 230-(S-(1-(3-((3-(2,3-DIHYDROXYPROPOXY)PROPYL)AMINO)-3-OXOPROPYL)-2,5-DIOXO-3-PYRROLIDINYL)-L-CYSTEINE) 230,230-DIETHER WITH .ALPHA.-METHYL-.OMEGA.-HYDROXYPOLY(OXY-1,2-ETHANEDIYL)

PEGRISEPRUMENT [USAN]

PEGRIZEPRUMENT [INN]

VH-CH1 CHAIN (1-232) (VH MUSMUS/HOMSAP (MUS MUSCULUS IGHV1-62-2*01 (84.0%) -(IGHD) -IGHJ3*01 (100%)/HOMO SAPIENS IGHV1-2*02 (63.3%) -(IGHD) -IGHJ4*01 (91.7%) S128>A (121), CDR-IMGT (8.8.14) (26-34.51-58.97-110)) (1-121) -HOMO SAPIENS IGHG1*01 CH1-H, G1M17 CH1 K120 (CH1 K120 (218) (122-219), HINGE 1-11 (220-230) -2-MER BISALANYL (231-232)) (122-232)), (224-214')-DISULFIDE WITH L-KAPPA LIGHT CHAIN (1'-214') (V-KAPPA MUSMUS/HOMSAP (MUS MUSCULUS IGKV12-46*01 (83.2%) -IGKJ1*01 (100%)/HOMO SAPIENS IGKV1-NL1*01 (74.4%) -IGKJ2*02 (91.7%) Q120>G (100'), CDR-IMGT (6.3.9) (27'-32'.51'-53'.89'-97')) (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153'), V101 (191') (108'-214')), PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, EXPRESSING THE ENZYME GLUTAMINE SYNTHETASE (GS), NON-GLYCOSYLATED; SUBSTITUTED AT THE SULFUR ATOMS OF L-CYSTEINYL RESIDUE 230 WITH GROUP (3.XI.)-1-(3-((3-((2.XI.)-2,3-BIS(.OMEGA.-METHOXYPOLY(OXYETHYLENE)-.ALPHA.-YL)PROPOXY)PROPYL)AMINO)-3-OXOPROPYL)-2,5-DIOXOPYRROLIDIN-3-YL